https://www.selleckchem.com/pr....oducts/ch5183284-deb
Most patients with symptomatic HHE can be managed successfully with a combination of medical, radiological and surgical treatments. Patients with diffuse lesions, late presentation, cardiac failure and type II histology have a poor outcome. Diagnostic level IV. Therapeutic level IV. Diagnostic level IV. Therapeutic level IV. Palonosetron, a long-acting 5-HT receptor antagonist, is an effective antiemetic agent for chemotherapy-induced nausea and vomiting; however, it sometimes causes severe constipation. The aim of the pres
Like
Comment
Share
